201275-65-2

Basic information

• Product Name: Z-D-THR(TBU)-OH DCHA
• Synonyms: N-ALPHA-CBZ-O-T-BUTYL-D-THREONINE DICYCLOHEXYLAMMONIUM SALT;N-ALPHA-CARBOBENZOXY-O-T-BUTYL D-THREONINE DICYCLOHEXYLAMMONIUM SALT;Z-D-THREONINE(TBU)-OH DCHA;Z-D-THR(TBU)-OH DCHA;Z-O-T-BUTYL-D-THREONINE DICYCLOHEXYLAMMONIUM SALT;Cbz-D-Thr(tBu)-OHDCHA;Z-D-Thr(tBu)-OH;FMoc-D-Tyr(Me)
• CAS NO: 201275-65-2
• Molecular Formula: C28H46N2O5
• Molecular Weight: 490.68
• Mol File: 201275-65-2.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Store at RT.
• CAS DataBase Reference: Z-D-THR(TBU)-OH DCHA(CAS DataBase Reference)
• NIST Chemistry Reference: Z-D-THR(TBU)-OH DCHA(201275-65-2)
• EPA Substance Registry System: Z-D-THR(TBU)-OH DCHA(201275-65-2)

Safety Data

• Hazardous Substances Data: 201275-65-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
Z-D-THR(TBU)-OH DCHA is used as a key component in the development of new drugs for the treatment of various diseases, including cancer and neurodegenerative disorders, due to its potential therapeutic applications and unique chemical properties.
Used in Drug Discovery:
Z-D-THR(TBU)-OH DCHA is employed as a valuable tool in drug discovery, aiding researchers in understanding the compound's interactions with biological targets and its potential as a therapeutic agent.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, Z-D-THR(TBU)-OH DCHA is utilized for its unique structure and properties, enabling researchers to explore its potential in the design and synthesis of novel therapeutic agents.
Used in Cancer Treatment Research:
Z-D-THR(TBU)-OH DCHA is used as a research compound for investigating its potential as a therapeutic agent in the treatment of various types of cancer, given its role in protein synthesis and metabolic functions.
Used in Neurodegenerative Disorder Research:
Z-D-THR(TBU)-OH DCHA is also used in research aimed at developing treatments for neurodegenerative disorders, leveraging its potential to influence protein synthesis and metabolic pathways relevant to these conditions.